Figure 4.
MK-4 is a ferroptosis inhibitor. (A–H) Western blot analysis of Sirt3, SLC7A11, ALOX12 and ferroptosis-related expression in SI-ALI. (I). Histology and immunohistochemical analysis of GPX4 levels in the different groups. Magnification: ×200 and ×400. (J) Lung injury score. (K) Quantification of the relative expression of GPX4. “*” indicates a significant difference between the corresponding groups (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).